维力医疗：第六批国家医用耗材集采不涉及狼和医疗的产品

Core Viewpoint - Weili Medical (603309.SH) announced that the sixth batch of national medical consumables procurement does not involve Wolf and Medical products, indicating a potential impact on the company's financials due to the acquisition of Wolf and Medical [2] Group 1: Financial Implications - The company has preliminarily assessed that goodwill arising from the acquisition of Wolf and Medical has shown signs of impairment based on the operational status projected for 2025 [2] - To reflect the financial status and asset value more objectively and fairly, the company plans to recognize goodwill impairment for the fiscal year 2025, with the final impairment amount to be determined by an evaluation and auditing firm [2] - The financial data for Q4 2025 has not yet been disclosed, and stakeholders are advised to pay attention to subsequent periodic reports for detailed descriptions and breakdowns of quarterly data [2] Group 2: Performance Forecast - The 2025 performance forecast data provided by the company is based on preliminary calculations from the finance department, with the accurate financial data to be confirmed in the officially disclosed audited annual report for 2025 [2]